Innovation, Moonshots, Brain, Healthtech, Stroke.
it’s a mission.” It’s also very personal: Corkhill’s mother-in-law died of a stroke. Neuralert is focusing on a very specific initial market, which is patients coming out of high-stroke-risk cardiovascular surgery or procedures. There are around two million of these procedures done in the US each